Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 1 other study
10,018people with cardiovascular disease, in this paper
The trial randomly assignedassigned by chance
nateglinide
placebo
No clear effect on MI, non-fatal stroke and HF−15%
randomisedthe abstract, start to end
… (1.8%) versus 100/4661 (2.1%) - (HR 0.85; 95% CI 0.64 to 1.14; P = …
← favours treatmentfavours comparator →
could be chanceMI, non-fatal stroke and HFnateglinide vs placebo
HR 0.850.64–1.14
Sulfonylureas & glinidesCardiovascular events
Sulfonylureas & glinides × cardiovascular eventshelps?replicated
unlikelylikely
0.96not counted
← favours treatmentfavours comparator →
1 / 6